11/7
11:30 pm
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
High
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
11/7
11:30 pm
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
High
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.